Jul 1 |
Solid Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
|
Jul 1 |
Solid Biosciences Joins the Russell 3000® Index
|
Jun 21 |
Solid Biosciences rises 15% off expanded Sarepta Duchenne indication
|
Jun 2 |
We Think Solid Biosciences (NASDAQ:SLDB) Can Afford To Drive Business Growth
|
May 15 |
Solid Biosciences reports Q1 results
|
May 15 |
Solid Biosciences Provides First Quarter 2024 Business Update and Financial Results
|
May 7 |
Solid Biosciences to Present at the American Society of Gene and Cell Therapy Annual Meeting
|
Apr 10 |
Buy Solid Biosciences: Unpacking Its Main Value Driver
|
Apr 3 |
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
Apr 2 |
Solid Biosciences (SLDB) Falls Despite FDA Rare Tag for DMD Drug
|